MIDAZOLAM
- Product NDC
- 51662-1237
- 11-digit product format
- 516621237
- Labeler code
- 51662
- Product ID
- 51662-1237_a09ca1d0-f18d-eb49-e053-2a95a90ad5d2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- MIDAZOLAM
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA075857
- Marketing category
- ANDA
- Marketing start
- 2018-09-16
- Marketing end
- 2021-05-01
- Substance
- MIDAZOLAM HYDROCHLORIDE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51662-1237-1 | 51662123701 | 1 mL in 1 VIAL, SINGLE-DOSE (51662-1237-1) | 1 ml | 2018-09-16 | 2021-05-01 | No | No | Current |